|
Originally published In Press as doi:10.1074/jbc.M200307200 on April 8, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24073-24080, July 5, 2002
Type I Shorthorn Sculpin Antifreeze Protein
RECOMBINANT SYNTHESIS, SOLUTION CONFORMATION, AND ICE
GROWTH INHIBITION STUDIES*
Kayesh
Fairley §,
Belinda J.
Westman§¶,
Linda H.
Pham ,
A. D. J.
Haymet **,
Margaret M.
Harding  , and
Joel P.
Mackay§§§
From the School of Chemistry and the
§ Department of Biochemistry, University of Sydney, New
South Wales 2006, Australia and the Department of Chemistry,
University of Houston, Houston, Texas 77204-5003
Received for publication, January 11, 2002, and in revised form, March 25, 2002
 |
ABSTRACT |
A number of structurally diverse
classes of "antifreeze" proteins that allow fish to survive in
sub-zero ice-laden waters have been isolated from the blood plasma of
cold water teleosts. However, despite receiving a great deal of
attention, the one or more mechanisms through which these proteins act
are not fully understood. In this report we have synthesized a type I
antifreeze polypeptide (AFP) from the shorthorn sculpin
Myoxocephalus scorpius using recombinant methods.
Construction of a synthetic gene with optimized codon usage and
expression as a glutathione S-transferase fusion protein
followed by purification yielded milligram amounts of polypeptide with
two extra residues appended to the N terminus. Circular dichroism and
NMR experiments, including residual dipolar coupling
measurements on a 15N-labeled recombinant polypeptide, show
that the polypeptides are -helical with the first four residues
being more flexible than the remainder of the sequence. Both the
recombinant and synthetic polypeptides modify ice growth, forming
facetted crystals just below the freezing point, but display negligible
thermal hysteresis. Acetylation of Lys-10, Lys-20, and Lys-21 as
well as the N terminus of the recombinant polypeptide gave a derivative
that displays both thermal hysteresis (0.4 °C at 15 mg/ml)
and ice crystal faceting. These results confirm that the N terminus of
wild-type polypeptide is functionally important and support our
previously proposed mechanism for all type I proteins, in which the
hydrophobic face is oriented toward the ice at the ice/water interface.
 |
INTRODUCTION |
The type I AFPs1 found in the blood of cold water
teleosts (1-3) have attracted
significant interest, due to the potential applications of such
compounds in biotechnology and medicine (4-9). These compounds are
alanine-rich -helical proteins of 33-47 residues in length (for
reviews see Refs. 10-13). Although 14 type I proteins have been
identified in nature (summarized in Ref. 12), almost all studies to
date have centered on HPLC6, the 37-residue protein from the winter
flounder (see Table I below) (14). This protein is characterized as an
AFP, because it modifies both the rate and shape of ice crystal growth
and displays thermal hysteresis, i.e. a positive difference
between the ice growth temperature and the equilibrium melting
temperature of ice.
During the last decade, significant progress has been made in
elucidating the structural features of HPLC6 that are required to give
antifreeze activity. Structure-activity studies have identified the
importance of the Thr residues at positions 2, 13, 24, and 35 plus
surrounding residues, for ice growth inhibition activity. Although the
Thr residues were assumed to be involved in hydrogen-bonding interactions with ice for many years (15-19), more recent mutations have identified the hydrophobicity provided by the -methyl group of
Thr as a key factor related to the ability to inhibit ice growth (20-24). Hydrogen bonding and other roles for the surrounding residues have also been considered (24-29). However, a model that explains the
selective interaction of HPLC6 with the [2 0 1] interface has
not emerged (for a full description of the different ice interfaces see
the previous review (12)). Recent computational studies on the nature
of the ice/water interface have allowed the first real simulations of
the interaction of HPLC6 with the fluid interface to be carried out
(30). These studies support experimental data on mutants (20-24) that
have shown that hydrogen bonding involving the hydroxyl groups of the
four Thr residues is not the primary reason for the interaction of HPLC
with the ice/water interfacial region.
In contrast to HPLC6, type I AFPs from the grubby sculpin
(Myoxocephalus aenaeus) (31), the shorthorn sculpin
(Myoxocephalus scorpius) (3, 32), and the Arctic sculpin
(Myoxocephalus scorpioides) (33) have been much less
studied. These proteins differ from both HPLC6 and sequences from the
right-eye flounders in the N-terminal region of the sequence. The
N-terminal residues of the sculpin proteins (e.g. SS3, SS8
in Table I) include established helix-breaking residues followed by an
11-residue repeat unit that is similar to the
Thr-X2-Asx-X7 repeat
present in the other type I proteins (12).
Two proteins, XSS3 and XSS8 (Table I), have been isolated from the
blood serum of the shorthorn sculpin (3). It has been estimated using
CD spectroscopy that XSS8, the major component, is more helical than
XSS3, and it has been proposed that there are two different structural
and possibly functional domains, the nine-residue N terminus and the
alanine-rich helical region between residues 8 and 42 (3). Vacuum phase
molecular dynamics studies on SS8, a closely related sequence to XSS8,
concluded that the polypeptide conformation resembles an idealized
-helix, except for a short section of the N-terminal region (34).
This study also proposed that SS8 acts via insertion of the side chains of the Arg and Lys residues into the ice lattice. However, no experimental or condensed-phase computational evidence exists to
support these conclusions. Of particular significance is the fact that
the sculpin proteins accumulate specifically at a different ice plane
than the winter flounder protein HPLC6 (15). The origin of this
difference in specificity between the flounder and sculpin proteins is
not understood and must eventually be explained by any proposed
model(s) of ice growth inhibition by the type I AFPs. Recent
structure-activity studies on SS8 (that was independently isolated and
resequenced) propose a mechanism that involves appreciable hydrophobic
interactions, with the lysine residues enhancing solubility (35).
The lack of understanding of the one or more mechanisms through which
the type I AFPs inhibit ice growth has also hampered the realization of
industrial and biotechnological applications (6, 7). Furthermore, the
production of these proteins using solid-phase synthesis (which has
been used to produce almost all the analogues of HPLC6 reported to
date) is unsuitable for the large scale production of structural
variants of the wild-type proteins. In this paper, we address both
these issues by producing a type I polypeptide from the shorthorn
sculpin (rSS3) using recombinant methods.2 This has allowed
complete 1H and 15N resonance assignments and
characterization of the solution conformation of rSS3 using
heteronuclear NMR experiments. Ice growth inhibition studies on rSS3
and an acetylated derivative have provided important new clues
regarding the mechanism of action of these proteins and have allowed a
new contribution to the mechanism to be proposed to explain the unique
interaction of the sculpin AFPs with ice.
 |
EXPERIMENTAL PROCEDURES |
Materials--
SS3 prepared by solid-phase peptide synthesis
(sSS3) was supplied by Auspep Pty. Ltd. (Melbourne) at >90% purity.
Cloning and Overexpression of rSS3--
A synthetic gene
encoding SS3 was constructed from the following three overlapping
primers: 1) AFP1 (GG GGA TCC ATG AAC GCT CCG GCA CGT GCA GCT GCG AAA
ACT GCA GCT GAC GCA CTG GCT G), AFP2 (GCA GCA GCC GCA GCG TCT GCC GCG
GTT TTT TTT GCT GCA GCC AGT GCG TCA GCT GCA GTT), and AFP3 (CGG CAG ACG
CTG CGG CTG CGG CTG CTG CGG CAG CTG CTT AAT AGT GAG AAT TCG G) using
overlap extension (36). The three primers were annealed, and PCR was
used to fill the gaps. Two end primers, AFPPRIM1 (GG GGA TCC ATG AAC
GCT C) and AFPPRIM2 (CCG AAT TCT CAC TAT TAA GC), were then used to
amplify the gene by PCR. The amplified product was inserted into
pGEX-2T using the BamHI and EcoRI restriction
sites and used to transform Escheichia coli (DH5 ).
Transformant colonies selected for growth on ampicillin were screened
for the insert DNA by PCR. Plasmid DNA was purified from positive
clones and sequenced. Plasmid DNA from a single clone identified as
containing the rSS3 gene was used to transform
E. coli (BL21(DE3)) for protein production.
Overnight cultures from freshly transformed E. coli
BL21(DE3) cells were used to inoculate Luria broth containing 150 µg
ml 1 ampicillin. The cells were grown at 37 °C with
shaking (200 rpm), and expression was induced using
isopropyl-1-thio- -D-galactopyranoside (0.4 mM) when the absorbance at 600 nm
(A600) was ~0.6. The cells were allowed to
grow for a further 4-6 h at 25 °C and were then harvested by
centrifugation (15 min, 5000 × g, 4 °C). The cell pellets were resuspended in lysis buffer (20 mM Tris, pH
8.0; 150 mM NaCl; 0.5 mM phenylmethylsulfonyl
fluoride; 0.1% (v/v) -mercaptoethanol) and lysed by either
sonication or five passages through a Rannie Mini-lab 8.30H homogenizer
at 500 kPa.
The lysate was centrifuged (20 min, 15,000 × g,
4 °C), the insoluble fraction was discarded, and the soluble
fraction was passed through a column containing 15 ml of
glutathione-Sepharose 4B (Amersham Biosciences, Inc.) equilibrated with
lysis buffer. The column was washed with 100 ml of wash buffer (50 mM Tris, pH 8.0; 100 mM NaCl; 10% glycerol;
1.4 mM phenylmethylsulfonyl fluoride; 1.4 mM
-mercaptoethanol) and re-equilibrated with 120 ml of thrombin buffer
(50 mM Tris, pH 8.0; 150 mM NaCl; 2.5 mM CaCl2). After incubation with thrombin (100 units) for 1 h at 37 °C, the cleaved rSS3 was eluted with
thrombin buffer in four 25-ml fractions, snap frozen, and stored at
20 °C.
Large scale overexpression was carried out in a New Brunswick
Scientific Bioflow III Fermentor using the protocol of Cai et al. (37). Three-liter cultures were grown on a minimal medium, in
which the only source of nitrogen was ammonium chloride. For the
production of 15N-labeled SS3,
15NH4Cl (0.75 g) was added to the medium when
the dissolved oxygen content of the medium increased sharply
(indicating exhaustion of the ammonium chloride). Following a second
increase in dissolved oxygen content, 3.75 g of
15NH4Cl was added, overexpression was induced,
and the culture was allowed to grow for a further 5 h before
harvesting as described above.
HPLC Purification--
All recombinant samples were purified by
reverse-phase HPLC using an Alltech Altima 5-µm C18 column. A linear
AB gradient was used (30-45% buffer B over 15 min for rSS3 and
15N-rSS3; 20-60% buffer B over 30 min for
4Ac-rSS3). In each case a flow rate of 1 ml/min was used, and
the eluate was monitored at 215 and 280 nm. The major peaks were
collected, lyophilized, and stored at 20 °C. The identity of rSS3
and 15N-rSS3 was confirmed by electrospray mass
spectrometry (rSS3: Mr,calc = 3084 Da;
Mr,expt = 3083 ± 1 Da;
15N-rSS3: Mr,calc = 3125 Da;
Mr,expt = 3124 ± 2 Da).
Acetylation of r-SS3--
rSS3 (4.0 mg) was dissolved in water
(50 µl) and sodium acetate solution (saturated, 50 µl)
added. The mixture was stirred at 0 °C, and acetic anhydride (10 µl, 9.4 µmol) was added in five equal amounts over 2 h. The
mixture was allowed to react for a further 2 h at 0 °C, and
then subjected to reverse phase HPLC; products were identified by
electrospray mass spectrometry. Products with three or fewer acetyl
groups were resubjected to the reaction conditions. Fractions
containing 4Ac-rSS3 were combined (Mr,calc = 3152 Da, Mr,expt = 3150 ± 5 Da).
Circular Dichroism Studies--
CD measurements were made using
a Jasco J-710 spectropolarimeter equipped with a 0.1-cm water-jacketed
cell connected to a NESLAB RTE-111 water bath. Peptide samples were
between 0.1 and 0.5 mg ml 1 in water or 100 mM
NH4HCO3 buffered solutions, at pH 8.5. The sample pH was adjusted using 0.1 M NaOH and HCl solutions
as required. Variable temperature measurements were made at regular
intervals between 2 °C and 50 °C. Sample concentrations for CD
and thermal hysteresis measurements were determined by amino acid
analysis, which was carried out by Baylor College of Medicine, Houston, TX. Helicity values were calculated by the method of Greenfield and
Fasman (38).
Thermal Hysteresis--
Ice crystals in a Clifton nanoliter
osmometer were observed through a microscope and photographed with a
digital camera, and time evolution was recorded by a video camera
linked to a video recorder (see Ref. 21). Still images were also
obtained from the videotape record at regular intervals over a period
of ~1 min. The absolute length scale in the video images was
determined from previous measurements of the absolute diameter of the
holes in the (unchanged) aluminum sample holder (21).
NMR Spectroscopy--
NMR samples of rSS3, 15N-rSS3,
and 4Ac-rSS3 were prepared by dissolving lyophilized peptide in 550 µl of 90% H2O/10% D2O to final
concentrations of 1 mM. The pH was adjusted to 5.0 using NaOH. The following homonuclear two-dimensional experiments were recorded: TOCSY ( m = 35, 70 ms; (39)), DQF-COSY (40),
and NOESY ( m = 70, 100, and 250 ms (41)).
Three-dimensional HNHA (42) and NOESY-HSQC (43) experiments were used
to assign the [15N,1H]HSQC spectrum of rSS3,
and the HNHA was used to derive 3JHNa coupling
constants. Spectral widths were typically 12 ppm for 1H and
30 ppm for 15N. 2,2-Dimethylsilapentane-5-sulfonic acid (20 µM) was added as an internal reference. Spectra were
recorded on Bruker DRX600 spectrometers equipped with an HCN
triple-resonance probe head. Water suppression was achieved by the use
of pulsed-field gradients, and quadrature detection in the indirect
dimensions was accomplished using the States-time proportional phase
incrementation method (43). Spectra were processed as described
previously (44) and were analyzed using the program XEASY (45).
Samples in aligned media for the measurement of residual dipolar
couplings were prepared using the method of Ruckert and Otting (46).
Briefly, polyoxyethylene 5-octyl ether was dissolved in 90%
H2O/10% D2O to a final concentration of 5%
(w/w), the pH was adjusted to 5.0, and 1-octanol was added in
microliter steps, with vigorous shaking, to a final molar ratio of 0.87 (polyoxyethylene 5-octyl ether:1-octanol). Formation of the
La phase was detected by the solution becoming
instantaneously transparent and opalescent. 15N-Labeled
rSS3 was added from a stock solution (1.2 mM, pH 5.0) to a
final concentration of 200 µM. All spectra were recorded at 278 K. Measurements of 1DHNN were
made by comparing 15N-HSQC spectra, recorded without
15N-decoupling in F2, in aligned and unaligned media.
 |
RESULTS |
Overexpression and Purification--
Because type I AFPs are
relatively small proteins (3000-5000 Da) that lack a globular
shape, they are potentially susceptible to degradation when expressed
in heterologous systems such as bacteria. For this reason rSS3 was
expressed as a fusion with the 26-kDa C-terminal domain of GST from
Schistosoma japonicum. This fusion protein was expected to
show greater stability in bacteria than rSS3 on its own, and indeed no
degradation was observed when expressed in E. coli. The
fusion protein was present in approximately equal amounts in the
insoluble and soluble components at 37 °C, and reduction of the
temperature at which the bacterial cells were induced from 37 °C to
25 °C resulted in ~80% soluble fusion protein (data not shown).
Cleavage of the bound protein between the GST and SS3 domains using the
site-specific protease thrombin resulted in the production of the
sculpin sequence with two additional residues (Gly-Ser) appended to the
N terminus (rSS3). Fig. 1 shows the
affinity purification of rSS3; the presence of a single band in lane 4 indicates that no appreciable breakdown of the SS3
portion of the fusion protein was observed. The yield from 4 liters of bacterial culture was 7.5 mg of rSS3, at >90% purity.

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 1.
Tricine SDS-PAGE gel of purification of
rSS3. Lane 1, molecular weight markers (Invitrogen);
lane 2, total soluble protein; lane 3,
flow-through; lane 4, GST-rSS3 fusion protein bound to
reduced glutathione-Sepharose; lane 5, bound GST following
thrombin cleavage; lane 6, purified rSS3.
|
|
The Solution Conformation of SS3--
To characterize the solution
conformation of SS3 and to ascertain whether the addition of two
non-native residues onto the N terminus had a significant effect on the
solution properties of the protein, we used a combination of circular
dichroism and NMR methods. CD spectra of sSS3 and rSS3 recorded over a
range of temperatures (Fig. 2) indicated
that both the synthetic and recombinant versions of SS3 are -helical
and that the helicity increased substantially as the temperature was
lowered. At 2 °C, rSS3 was estimated to be 40% -helical. This
value is comparable to the previously reported literature estimate of
45% for XSS3 (3).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
CD spectra of rSS3. Spectra were
recorded on 30 µM sample at pH 5.0 between 2 and
40 °C. Calculated helicity at 2 °C is 42%.
|
|
The 600-MHz 1H NMR spectrum of rSS3 was assigned using a
combination of three-dimensional HNHA and NOESY-HSQC experiments, together with DQF-COSY, TOCSY, and NOESY spectra, all recorded at
5 °C. Despite the high degree of signal overlap resulting from a
combination of the 25 alanine residues and the helical conformation, assignments were made for every resonance in the spectrum (Fig. 3). This result contrasts with the
difficulties experienced in previous NMR studies of the naturally
occurring type I AFP, HPLC6 (47, 48). In the current study, the
assignment process was assisted by the availability of uniformly
15N-labeled polypeptide 15N-rSS3, emphasizing
the utility of protein production in a recombinant system.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
600-MHz NMR spectra of rSS3 showing spin
system assignments. Spectra were recorded on a 1 mM
sample in 90% H2O at pH 5.0. a, TOCSY
experiment (mixing time 70 ms); b, 15N HSQC
spectrum. Side-chain protons are denoted SC.
|
|
Analysis of the NOESY spectra, in particular the amide-amide region
(Fig. 4), revealed many of the
characteristic connectivities expected for an -helix. A summary of
medium range NOEs, H chemical shift data, and
3JHN scalar coupling values is
presented in Fig. 5. For H
chemical shifts, a series of negative values for
(H )rSS3 (H )coil are indicative of helical
structure. The values were negative for all residues apart from
Gly-( 1)-Met-1, Ala-3, and Leu-15, consistent with most of the
polypeptide adopting an -helical conformation. Similarly, values of
3JHN , which are typically <~6
Hz for -helices (49), and NOE patterns support a predominantly
-helical conformation, although a number of the expected medium
range NOEs could not be unambiguously identified because of resonance
overlap.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 4.
Amide region of a 600-MHz NOESY spectrum of
rSS3. Spectra were recorded on a 1 mM sample in 90%
H2O at pH 5.0 with a mixing time of 250 ms. Sequential
dNN(i,i+1) connectivities typical of
an -helix are highlighted for residues 15-35.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
Summary of NMR parameters measured for
rSS3. Below the amino acid sequence, filled circles
identify residues with 3JHNH < 6.0 Hz, indicative of local -type conformation; crosses
identify residues with 3JHNH
values of 6.0-8.0 Hz. For the sequential NOE connectivities
(d N, dNN, and
d N) thin and thick bars
indicate strong and weak NOE intensity, respectively; bracketed
values are for X-Pro and Pro-X. Clearly
identified medium range NOEs are indicated by a black line
connecting the two residues, whereas overlapped NOEs are identified by
a light gray line. 1H chemical shift changes
relative to random coil values,  (1H ), are plotted
and ranged from 0.29 to 0.16 ppm; negative values are indicative of
an -helical conformation. Residual dipolar couplings,
1DHNN, are plotted at the
bottom. Values were measured for all protons directly
attached to nitrogen and covered the range 11.4 to 3.1 Hz. The
location of the identified -helix is shown at the
bottom.
|
|
An issue that often arises when using NMR methods to characterize the
solution conformation of rod-shaped proteins is that of whether the
overall shape is straight or bent. Most NMR-derived structural
constraints are short-range in nature (e.g. NOEs scalar coupling constants), and are therefore poorly suited to defining the
relative conformations of the two ends of a rod. However, residual
dipolar couplings, measured in weakly aligning media such as dilute
solutions of liquid crystals, have recently been shown to be well
suited to this task (50-52), and the availability of a recombinant
form of SS3 allows these parameters to be measured. We measured
residual 1H-15N dipolar couplings
(1DHN) for the backbone amide
protons of 15N-rSS3, and the results are shown at the
bottom of Fig. 5. The magnitude of these couplings is an
indication of the angle formed between the N-H bond vector and the
bulk magnetic field and can, therefore, be used to infer the angular
relationship between two N-H bond vectors within a single molecule.
The observation that the values of
1DHN are rather uniform across most
of the polypeptide is consistent with a conformation in which all N-H
bond vectors are oriented in approximately the same direction, as would
be expected for an -helix with no significant kink. Notably, the
values of 1DHN tail off toward zero
toward the N terminus, consistent with the helical structure in this
region being more flexible than the rest of the polypeptide. Further
refinement of this data to obtain a full structure would require
additional constraints from measurements on doubly labeled
(13C,15N) polypeptide.
Thermal Hysteresis of sSS3 and rSS3--
The thermal hysteresis
values for sSS3 and rSS3 were measured by nanoliter osmometry in
unbuffered aqueous solutions on 4 mM, 2 mM, and
1 mM polypeptide samples at pH 5; concentrations of each
stock solution were determined by amino acid analysis. Fig.
6a shows a single crystal of
ice grown from a solution of purified rSS3 at 16 mg/ml. The hexagon
bipyramidal crystals are characteristic of kinetic ice growth
inhibitors of this type. The behavior of sSS3 (>90% pure) was similar
but yielded truncated bipyramidal crystals or "barrels," again a
signature of ice modification. Similar barrels were obtained with an
independent sample of rSS3 of lower purity than the sample used to
obtain the crystals shown in Fig. 6a. Both sSS3 and rSS3
exhibited negligible hysteresis values of between zero and 0.02 °C
at concentrations up to 18 mg/ml (data not shown). The ability to facet
growing ice crystals, but not inhibit their growth at all, as shown by
both sSS3 and rSS3, is typical of polypeptides that interact weakly
with the broad ice/water interfacial region.

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 6.
Ice crystal morphology. Single ice
crystals grown in the presence of solutions of (a) rSS3 (18 mg ml 1) and (b) 4Ac-rSS3 (16 mg
ml 1). The long axis of each crystal is ~50
µm.
|
|
The wild-type protein isolated from blood serum (XSS3) has been
reported to exhibit measurable thermal hysteresis (3). Although no raw
data were presented, XSS3 was reported to give 0.39 degrees hysteresis
(~10 mg/ml, 0.02 M NH4HCO3),
whereas the second major protein isolated from the fish, XSS8, gave a
higher hysteresis value of 0.67 °C. Both proteins contained an
unknown blocking group at the N terminus (designated by X in
these sequences in Table I), and removal
of this group from XSS8 to give NH2SS8, decreased the
hysteresis by 0.41 degrees. Although the effect of the removal of the
blocking group from XSS3 was not reported, a similar reduction in
thermal hysteresis to that observed with XSS8 would result in
negligible thermal hysteresis, consistent with the results obtained
with rSS3 and sSS3.
Acetylation of rSS3--
To determine whether a post-translational
modification of SS3 may affect its ability to act as an AFP and to test
the hypothesis that the Lys/Arg residues are required for activity
(34), we chose to acetylate the free amino groups on the polypeptide.
Reaction of rSS3 with acetic anhydride under standard conditions,
followed by reverse-phase HPLC, yielded 4Ac-rSS3 in which all three
lysine residues and the N terminus were derivatized with acetyl groups. The identity of this polypeptide was confirmed by mass spectrometry and
NMR spectroscopy. Complete assignments of the 1H resonances
using two-dimensional NMR methods revealed that there were no
significant conformational changes in 4Ac-rSS3; all H resonances
were located less than 0.05 ppm from their position in the unacetylated peptide.
Remarkably, 4Ac-rSS3 exhibits not only faceting of growing ice crystals
(Figs. 6b and 7) but also
substantial thermal hysteresis (Fig. 8),
suggesting that either blockage of the N terminus and/or acetylation of
the three lysine residues (Lys-10, Lys-20, Lys-21) is important for
activity. The time evolution of an ice crystal is shown for the highest
concentration studied in Fig. 7.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 7.
Video microscopy. Ice crystal growth in
the presence of 4Ac-rSS3 (16 mg ml 1); still
images are taken at regular intervals over a period of 1 min. The
long axis of the largest crystal is ~50 µm. After the
last image, further lowering of the temperature by ~0.45 °C
produced no further ice growth, yielding the thermal hysteresis
reported in Fig. 8.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 8.
Thermal hysteresis. Measurements were
carried out in triplicate with 4Ac-rSS3 (pH 5) as a function of
concentration. Solid line is an approximate fit to guide the eye based
on the functional form of the Langmuir adsorption isotherm.
|
|
 |
DISCUSSION |
Compared with the type I winter flounder proteins (in particular
HPLC6), much less is known about the type I sculpin proteins. There are
no x-ray or NMR structures of AFPs from any of the sculpin proteins,
and, with the exception of a very recent report on SS8 (35), systematic
structure-activity studies to determine the residues that are crucial
for activity have not been reported. The sculpin proteins are
important, given that SS8 was proposed to interact with the ice surface
based on the spacing of Lys-9, Lys-23, Lys-31, and Arg-12 (34);
i.e. a completely different mechanism to that proposed for
HPLC6 and other synthetic flounder AFPs, including VVVV2KE, in which
hydrophobic interactions play a dominant role in the mechanism (21, 23,
24, 29, 30). We have previously noted that a common hydrophobic face is
present in all type I proteins, including the sculpins (12), and hence proposed that the type I AFPs act via a common mechanism. Very recently
this hypothesis has been confirmed by point mutations made on SS8,
which have identified the alanine-rich surface as oriented toward ice,
and the charged residues oriented toward liquid water (35).
Despite the presence of a common hydrophobic face in all type I AFPs
(12), the sculpins accumulate at a different ice plane than
the flounder proteins; the winter flounder sequence HPLC6 (and the
synthetic mutant VVVV2KE) accumulates on the 12 equivalent {2 0 1} bipyramidal planes of the ice 1h crystal (15) whereas the
shorthorn sculpin (and the synthetic mutant AAAA2KE) accumulates on the
six equivalent {2 0} planes (34) (for a detailed description of the origin and naming of the different ice planes see
for example Ref. 12). The origin of this difference is not understood,
but an obvious structural difference between the natural flounder and
sculpin sequences is the N-terminal region of the polypeptides (Table
I).
We chose SS3, as one of the simplest sculpin proteins, to prepare and
investigate the solution conformation, particularly of the N-terminal
region, and to allow preparation of a simple acetylated derivative that
would establish the residues that are required for antifreeze activity.
A highly effective expression system for production of the protein as a
GST fusion was developed, which yielded milligram quantities of
purified rSS3 from a few liters of bacterial culture. After affinity
chromatography and reverse-phase HPLC, rSS3 was >99% pure, a level of
purity much greater than sSS3, or other related proteins that our
laboratory has produced using solid-phase peptide synthesis (21, 23, 53). Thus, in our hands, the expression of rSS3 is superior to
solid-phase production of sSS3 in terms of the time required for the
synthesis, overall cost, and the purity of the isolated protein. The
recombinant system also offers the additional advantages of simple and
inexpensive production of mutants (which may be used for mechanistic or
biotechnological studies) and the ability to produce isotopically
labeled forms of the protein (e.g. 15N-rSS3 or
15N,13C-rSS3) for detailed structural analysis
using NMR spectroscopy.
Although CD measurements are consistent with ~42% helicity at
2 °C, NMR studies (Figs. 3 and 4) provide clear evidence that rSS3
is highly structured and predominantly -helical in conformation at
low temperature. Examination of the NMR parameters presented in Fig. 5
suggests that residues 5-33 of rSS3 adopt a stable -helical conformation, whereas residues 1-4 are partially helical. This corresponds to an overall helicity of ~80-90% (taking into account the non-native residues 2 and 1 that were introduced by the cloning
procedure). It is interesting that there is such a large apparent
difference between the estimates of helicity based on CD and NMR data.
This is most likely related to the method used to estimate helicity
from CD data (38), which is not well suited to proteins containing
non-helical secondary structure. Alternatively, there may be some
flexibility in the helix (especially near the termini) that reduces the
CD value and is not accurately reflected in the NMR parameters we have
measured. This issue will be resolved when a full structure
determination is carried out using more NMR data.
For comparison, vacuum modeling has predicted that SS8 adopts a fully
-helical conformation (34), whereas more recent molecular dynamics
calculations on SS8 have predicted that the N-terminal cap structure
folds the N terminus up and away from the Ala-rich surface of the
protein (35). Although direct comparisons between the conformation of
residues 1-10 of SS3 and SS8 cannot be made, our results suggest that
the first 10 residues of SS3 are aligned approximately parallel to the
-helix formed by residues 11-33, with no significant deviation
similar to that predicted for SS8 (35). Further structural constraints
derived from 15N,13C-labeled protein (including
13C-X residual dipolar couplings) are required
to fully refine the structure.
Although both sSS3 and rSS3 cause faceting of the ice crystals to
occur, zero or very low thermal hysteresis values were measured. Thus,
both polypeptides behave as ice growth modifiers (12) rather than as
true kinetic ice growth inhibitors or AFPs. The measured hysteresis
value is significantly lower than that reported from SS3 isolated from
sculpin blood serum (3). However, both of the naturally occurring
sculpin proteins XSS3 and XSS8 isolated and characterized by Hew
et al. (3) contained an uncharacterized blocked N terminus.
In the case of SS8, cleavage of this blocking group reduced the thermal
hysteresis (Table I). Thus, the difference between the measured
hysteresis values for sculpin XSS3 (0.37 °C) and the synthetic
sSS3/rSS3 polypeptides (0.0 °C) is consistent with the requirement
of an N-terminal blocking group for activity.
The thermal hysteresis and characteristic ice faceting of 4Ac-rSS3
(Figs. 6-8) show that not only is this derivative a true kinetic ice
growth inhibitor, but also that this derivative is more active than
rSS3, which exhibited negligible hysteresis. These results conclusively
rule out an inserted charge mechanism, similar to that proposed for SS8
involving the protonated lysine amino groups and the arginine side
chain (34) and support our earlier hypothesis that the hydrophobic face
is important in the mechanism of ice growth in both the winter flounder
and sculpin proteins (12). Our hypothesis is also supported by the very recent work by Baardnes et al. (35) on SS8 in which point
mutations of the hydrophobic face were seen to switch off antifreeze
activity. This study also identified the blocking group as an acetyl
group and, although SS3 was not studied, it seems plausible that the blocking group X is the same in both SS3 and SS8.
Fig. 9 shows a helical wheel
representation of SS3 with the hydrophilic face containing the
highlighted lysine residues proposed to be oriented toward liquid
water. The increase in hysteresis that occurred following acetylation
of rSS3 is consistent with two current hypotheses. First, it supports a
role for the N-terminal group in activity, originally proposed by Hew
et al. (3). The N-terminal blocking group may affect several
properties of the polypeptide, including overall charge, dipole moment,
N-terminal capping network, and solution conformation, all of which
need to be considered in further refinement of the mechanism for ice growth inhibition.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 9.
Helical wheel representation of SS3.
Lysine residues that are acetylated in 4Ac-rSS3 are shown in bold on
the hydrophilic face which is opposite the hydrophobic face. Similar
hydrophobic faces in type I AFPs have previously been noted in
reference (12).
|
|
In addition, our recent studies have shown that there is significant
charge inhomogeneity at the ice/water interface (54, 55). The full
charge distribution of SS3, or any polypeptide, interacts with
the charge inhomogeneity that occurs naturally at any broad interface
such as the ice/water interface. This full charge distribution may be
summarized crudely by the dipole moment of the polypeptide. Thus we
have proposed that, next in importance to hydrophobicity, the overall
charge distribution of the polypeptide is a crucial factor that
influences the exact interface at which the polypeptide accumulates
(55). A consequence of this hypothesis is that enhancing the charge
distribution in the polypeptide will increase the strength of the
interaction with the ice/water interface (55) and lead to greater
thermal hysteresis. Hence, the observed increased thermal hysteresis of
the acetylated derivative 4Ac-rSS3 compared with rSS3, which enhances
the molecular charge distribution, is consistent with this hypothesis.
However, slightly different conformations of the native protein from
the fish, rSS3, and 4Ac-rSS3 cannot be ruled out as contributor
to the different thermal hysteresis values. Further NMR studies to
determine full structures of these AFPs would be informative in this regard.
In summary, this study reports the first recombinant production,
solution conformation, and preparation and ice growth inhibition properties of an acetylated derivative of the 33-residue AFP from the
shorthorn sculpin. Together with recent independent studies on the
42-residue shorthorn sculpin AFP, SS8 (35), these data confirm our
hypothesis (12) that all type I AFPs contain a common hydrophobic face
that is required for antifreeze activity. Beyond supporting the
hydrophobicity mechanism, the data are consistent both with a proposed
role for the N-terminal blocking group (3) and with the proposed role
of the interaction of the overall charge distribution of the peptide
with the ice/water interface (55). The complete details of the
accumulation of SS3 at the specific {2 0} ice plane
require further detailed molecular simulations and experimental studies.
 |
FOOTNOTES |
*
This research was supported in part by a University of
Sydney Sesquicentennial Research and Development Grant (to M. M. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
Supported by the Welch Foundation and Grant ARP
003652- 0303-1999.
¶
Supported by an Australian Postgraduate Award.

To whom correspondence may be addressed: The School of
Chemistry, University of Sydney, New South Wales 2006, Australia. Tel.: 61-2-9351-2745; Fax: 61-2-9351-6650; E-mail:
harding@chem.usyd.edu.au.
§§
An ARC Research Fellow. To whom correspondence may be addressed:
The Department of Biochemistry, University of Sydney, New South Wales
2006, Australia. Tel.: 61-2-9351-3906; Fax: 61-2-9351-4726; E-mail: j.mackay@biochem.usyd.edu.au.
Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M200307200
2
Presented in part at the IUPAC World Chemistry
Congress, Brisbane, Australia, July 2001 and the Novartis
Foundation/Royal Society Discussion Meeting, London, UK, September 28, 2001.
 |
ABBREVIATIONS |
The abbreviations used are:
AFP, antifreeze
polypeptide;
SS, shorthorn sculpin;
HPLC, high performance liquid
chromatography;
CD, circular dichroism;
GSH, glutathione;
GST, glutathione S-transferase;
TFA, trifluoroacetic acid;
TOCSY, total correlation spectroscopy;
NOESY, nuclear Overhauser effect
spectroscopy;
DQF-COSY, double-quantum filtered correlation
spectroscopy;
HSQC, homonuclear single quantum
coherence.
 |
REFERENCES |
| 1.
|
Duman, J. G.,
and DeVries, A. L.
(1974)
Nature
247,
237-238[CrossRef]
|
| 2.
|
Duman, J. G.,
and DeVries, A. L.
(1976)
Comp. Biochem. Physiol. B
54,
375-380[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hew, C. L.,
Joshi, S.,
Wang, N.-C.,
Kao, M.-H.,
and Ananthanarayanan, V. S.
(1985)
Eur. J. Biochem.
151,
167-172[Medline]
[Order article via Infotrieve]
|
| 4.
|
Chao, H.,
Davies, P. L.,
and Carpenter, J. F.
(1996)
J. Exp. Biol.
199,
2071-2076[Abstract]
|
| 5.
|
Brown, C. J.
(1997)
Can. Med. Assoc. J.
156,
629
|
| 6.
|
Fletcher, G. L.,
Goddard, S. V.,
and Wu, Y. L.
(1999)
Chemtech
29,
17-28
|
| 7.
|
Feeney, R. E.,
and Yeh, Y.
(1998)
Trends Food Sci. Technol.
9,
102-106
|
| 8.
|
Rubinksy, B.
(2000)
Ann. Rev. Biomed. Eng.
2,
157-187[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Wang, J.-H.
(2000)
Cryobiology
41,
1-9[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Yeh, Y.,
and Feeney, R. E.
(1996)
Chem. Rev.
96,
601-617[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Davies, P. L.,
and Sykes, B. D.
(1997)
Curr. Opin. Struct. Biol.
7,
828-834[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Harding, M. M.,
Ward, L. G.,
and Haymet, A. D. J.
(1999)
Eur. J. Biochem.
264,
653-665[Medline]
[Order article via Infotrieve]
|
| 13.
|
Ewart, K. V.,
Lin, Q.,
and Hew, C. L.
(1999)
Cell. Mol. Life Sci.
55,
271-283[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Fourney, R. M.,
Joshi, S. B.,
Kao, M. H.,
and Hew, C. L.
(1984)
Can. J. Zool.
62,
28-33
|
| 15.
|
Knight, C. A.,
Cheng, C.-H. C.,
and DeVries, A. L.
(1991)
Biophys. J.
59,
409-418[Medline]
[Order article via Infotrieve]
|
| 16.
|
Chou, K. C.
(1992)
J. Mol. Biol.
223,
509-517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Wen, D.,
and Laursen, R. A.
(1992)
Biophys. J.
63,
1659-1662[Medline]
[Order article via Infotrieve]
|
| 18.
|
Jorgensen, H.,
Mori, M.,
Matdui, H.,
Kanaoka, M.,
Yanagi, H.,
Yabusaki, Y.,
and Kikuzono, Y.
(1993)
Protein Eng.
6,
19-27[Abstract/Free Full Text]
|
| 19.
|
Lal, M.,
Clark, A. H.,
Lips, A.,
Ruddock, J. N.,
and White, D. N. J.
(1993)
Faraday Discuss. Chem. Soc.
95,
299-306[CrossRef]
|
| 20.
|
Chao, H.,
Houston, M. E.,
Hodges, R. S.,
Kay, C. M.,
Sykes, B. D.,
Loewen, M. C.,
Davies, P. L.,
and Sönnichsen, F. D.
(1997)
Biochemistry
36,
14652-14660[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Haymet, A. D. J.,
Ward, L. G.,
Harding, M. M.,
and Knight, C. A.
(1998)
FEBS Lett.
430,
301-306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Zhang, W.,
and Laursen, R. A.
(1998)
J. Biol. Chem.
273,
34806-34812[Abstract/Free Full Text]
|
| 23.
|
Haymet, A. D. J.,
Ward, L. G.,
and Harding, M. M.
(1999)
J. Am. Chem. Soc.
121,
941-948[CrossRef]
|
| 24.
|
Baardsnes, J.,
Kondejewski, L. H.,
Hodges, R. S.,
Chao, H.,
Kay, C.,
and Davies, P. L.
(1999)
FEBS Lett.
463,
87-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Sicheri, F.,
and Yang, D. S. C.
(1995)
Nature
375,
427-431[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Wen, D.,
and Laursen, R. A.
(1993)
FEBS Lett.
317,
31-34[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Cheng, A. L.,
and Merz, K. M.
(1997)
Biophys. J.
73,
2851-2873[Medline]
[Order article via Infotrieve]
|
| 28.
|
McDonald, S. M.,
White, A.,
Clancy, P.,
and Brady, J. W.
(1995)
AIChE J.
41,
959-973[CrossRef]
|
| 29.
|
Loewen, M. C.,
Chao, H. M.,
Houston, M. E.,
Baardsnes, J.,
Hodges, R. S.,
Kay, C. M.,
Sykes, B. D.,
Sönnichsen, F. D.,
and Davies, P. L.
(1999)
Biochemistry
38,
4743-4749[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Dalal, P.,
Knickelbein, J.,
Haymet, A. D. J.,
Sönnichsen, F. D.,
and Madura, J. D.
(2001)
Phys. Chem. Commun.
7,
1-5
|
| 31.
|
Chakrabartty, A.,
Hew, C. L.,
Shears, M.,
and Fletcher, G.
(1988)
Can. J. Zool.
66,
403-408
|
| 32.
|
Fletcher, G. L.,
Addison, R. F.,
Slaughter, D.,
and Hew, C. L.
(1982)
Arctic
35,
302-306
|
| 33.
|
Yang, D. S. C.,
Sax, M.,
Chakrabartty, A.,
and Hew, C. L.
(1988)
Nature
333,
232-237[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Wierzbicki, A.,
Taylor, M. S.,
Knight, C. A.,
Madura, J. D.,
Harrington, J. P.,
and Sikes, C. S.
(1996)
Biophys. J.
71,
8-18[Medline]
[Order article via Infotrieve]
|
| 35.
|
Baardnes, J.,
Jelokhani-Niaraki, M.,
Kondejewski, L. H.,
Kuiper, M. J.,
Kay, C. M.,
Hodges, R. S.,
and Davies, P. L.
(2001)
Protein Sci.
10,
2566-2576[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Higuchi, R.,
Krummel, B.,
and Saiki, R. K.
(1988)
Nucleic Acids Res.
16,
7351-7367[Abstract/Free Full Text]
|
| 37.
|
Cai, M.,
Huang, Y.,
Sakaguchi, K.,
Clore, G. M.,
Gronenborn, A. M.,
and Craigie, R.
(1998)
J. Biomol. NMR
11,
97-102[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Greenfield, N.,
and Fasman, G. D.
(1969)
Biochemistry
8,
4108-4116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Bax, A.,
and Davis, D. G.
(1985)
J. Magn. Reson.
65,
355-360
|
| 40.
|
Rance, M.,
Sorensen, O.,
Bodenhausen, G.,
Wagner, G.,
Ernst, R.,
and Wuthrich, K.
(1983)
Biochem. Biophys. Res. Commun.
117,
479-485[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Kumar, A.,
Ernst, R. R.,
and Wüthrich, K.
(1980)
Biochem. Biophys. Res. Commun.
95,
1-6[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Vuister, G. W.,
and Bax, A.
(1993)
J. Am. Chem. Soc.
115,
7772-7777[CrossRef]
|
| 43.
|
Marion, D.,
Driscoll, P. C.,
Kay, L. E.,
Wingfield, P. T.,
Bax, A.,
Gronenborn, A. M.,
and Clore, G. M.
(1989)
Biochemistry
28,
6150-6156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Kowalski, K.,
Czolij, R.,
King, G. F.,
Crossley, M.,
and Mackay, J. P.
(1999)
J. Biomol. NMR
13,
249-261[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Bartels, C.,
Xia, T. H.,
Billeter, P.,
Guntert, P.,
and Wüthrich, K.
(1995)
J. Biomol. NMR
6,
1-10
|
| 46.
|
Ruckert, M.,
and Otting, G.
(2000)
J. Am. Chem. Soc.
122,
7793-7797[CrossRef]
|
| 47.
|
Gronwald, W.,
Chao, H.,
Reddy, D. V.,
Davies, P. L.,
Sykes, B. D.,
and Sönnichsen, F. D.
(1996)
Biochemistry
35,
16698-16704[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Sönnichsen, F. D.,
Davies, P. L.,
and Sykes, B. D.
(1998)
Biochem. Cell Biol.
76,
284-293[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Bystrov, V. F.
(1976)
Prog. NMR. Spectrosc.
10,
41-81[CrossRef]
|
| 50.
|
Tolman, J. R.
(2001)
Curr. Opin. Struct. Biol.
11,
532-539[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Prestegard, J. H., Al-,
Hashimi, H. M.,
and Tolman, J. R.
(2001)
Q. Rev. Biophys.
33,
371-424
|
| 52.
|
Bax, A.,
Kontaxis, G.,
and Tjandra, N.
(2001)
Methods Enzymol.
339,
127-174[Medline]
[Order article via Infotrieve]
|
| 53.
|
Haymet, A. D. J.,
Ward, L. G.,
and Harding, M. M.
(2001)
FEBS Lett.
491,
285-288[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Hayward, J. A.,
and Haymet, A. D. J.
(2001)
J. Chem. Phys.
114,
3713-3726[CrossRef]
|
| 55.
| Bryk, T., and Haymet, A. D. J. (2002) J. Chem.
Phys., in press
|
| 56.
|
Cheng, C. C.,
and DeVries, A. L.
(1991)
in
Life under Extreme Conditions
(DiPrisco, G., ed)
, pp. 1-14, Springer-Verlag, Heidelberg, Germany
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|